⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3030219 | 0.75 | — | — | |
| SCHEMBL92892 | 0.73 | — | — | |
| SCHEMBL126328 | 0.72 | — | — | |
| SCHEMBL2446519 | 0.70 | — | — | |
| SCHEMBL30896661 | 0.70 | KDM4E (0.42) | — | |
| Ammonia Solution, Strong SCHEMBL31591123 | 0.70 | — | — | |
| SCHEMBL1149141 | 0.70 | KDM4E (0.42) | — | |
| Lithium Ion SCHEMBL3271653 | 0.69 | — | — | |
| SCHEMBL313226 | 0.69 | — | — | |
| Potassium Ion SCHEMBL6316224 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113271975-A | Method and kit for preparing pathogen inactivated whole blood | 塞鲁斯公司 | 2021-08-17 | — | — | CN | disclosed |
| US-20160347814-A1 | VSTM5 POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF CANCER, INFECTIOUS DISEASES AND IMMUNE RELATED DISEASES | COMPUGEN LTD (IL) | 2016-12-01 | — | — | US | disclosed |
| US-20160272707-A1 | VSTM5 ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCER, INFECTIOUS DISEASES AND IMMUNE RELATED DISEASES | COMPUGEN LTD. (IL) | 2016-09-22 | — | — | US | disclosed |
| US-7293985-B2 | Methods for quenching pathogen inactivators in biological materials | CERUS CORPORATION (US) | 2007-11-13 | — | — | US | disclosed |
| EP-1045704-B1 | METHODS FOR QUENCHING PATHOGEN INACTIVATORS IN BIOLOGICAL MATERIALS | CERUS CORP (US) | 2004-09-22 | — | — | EP | disclosed |
| US-20040180321-A1 | Methods for quenching pathogen inactivators in biological materials | CERUS CORPORATION (US) | 2004-09-16 | — | — | US | disclosed |
| WO-2004050897-A2 | METHODS FOR PREPARING ANTIGEN MASKED RED BLOOD CELLS HAVING REDUCED HEMOLYSIS BY SERA | CERUS CORPORATION (US) | 2004-06-17 | — | — | WO | disclosed |
| WO-2004050848-A2 | METHODS FOR ANTIGEN MASKING OF RED BLOOD CELLS RESULTING IN REDUCED HEMOLYSIS | CERUS CORPORATION (US) | 2004-06-17 | — | — | WO | disclosed |
| WO-2004049914-A2 | METHODS FOR REACTING AN ANTIGEN MASKING COMPOUND WITH RED BLOOD CELLS WITH HIGH EFFICIENCY | CERUS CORPORATION (US) | 2004-06-17 | — | — | WO | disclosed |
| US-6709810-B2 | SIDE EFFECT REDUCTION USING QUENCHER; STORAGE STABILITY | CERUS CORPORATION | 2004-03-23 | — | — | US | disclosed |
| US-6093725-A | A BINDER FOR DEACTIVATING PATHOGENS IN A BLOOD SAMPLE TO BIND NUCLEIC ACID BY COVALENT LINKAGE | CERUS CORPORATION (US) | 2000-07-25 | — | — | US | disclosed |
| EP-1005531-A2 | METHOD OF TREATING LEUKOCYTES, LEUKOCYTE COMPOSITIONS AND METHODS OF USE THEREOF | Cerus Corporation (US) | 2000-06-07 | — | — | EP | disclosed |
| WO-1999063981-A2 | USE OF ALKYLATING COMPOUNDS FOR INHIBITING PROLIFERATION OF ARTERIAL SMOOTH MUSCLE CELLS | CERUS CORPORATION (US) | 1999-12-16 | — | — | WO | disclosed |
| WO-1999034839-A1 | METHODS FOR QUENCHING PATHOGEN INACTIVATORS IN BIOLOGICAL MATERIALS | CERUS CORPORATION (US) | 1999-07-15 | — | — | WO | disclosed |
| US-5880076-A | PERSONAL PRODUCT OR DETERGENT COMPOSITION COMPRISING CYCLIC GLYCACARBAMATE AND/OR GLYCAUREA, SURFACTANT | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1999-03-09 | — | — | US | disclosed |
| WO-1999003976-A2 | METHOD OF TREATING LEUKOCYTES, LEUKOCYTE COMPOSITIONS AND METHODS OF USE THEREOF | CERUS CORPORATION (US) | 1999-01-28 | — | — | WO | disclosed |
| WO-1998030545-A9 | FRANGIBLE COMPOUNDS FOR PATHOGEN INACTIVATION | — | 1998-12-30 | — | — | WO | disclosed |
| WO-1998030545-A1 | FRANGIBLE COMPOUNDS FOR PATHOGEN INACTIVATION | CERUS CORPORATION (US) | 1998-07-16 | — | — | WO | disclosed |
| US-5641480-A | ENHANCED STABILITY AND/OR VISCOSITY, CLARITY | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1997-06-24 | — | — | US | disclosed |
| US-5041286-A | Appying oxidizing solution without rinsing reducing solution | YASMIN PRODUCTS PTY. LIMITED (AU) | 1991-08-20 | — | — | US | disclosed |